Safety of Mesenchymal Stem Cells Therapy in Patients with Inflammatory Bowel Diseases – 5 Year Follow-up

To compare safety profile of therapy in patients with ulcerative colitis (UC) and Crohn disease (?D), receiving anti-inflammatory therapy, using
bone marrow-derived mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicylic acid (5-ASA), glucocorticosteroids (GCS) and
immunosuppressive agents (IS).

 

View Full Article: HERE

Go through the Journal: http://www.enlivenarchive.org/genetic-molecular-and-cellular-biology

Contact Us: genetics@enlivenarchive.org

 

Leave a Reply

Your email address will not be published. Required fields are marked *